Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Each program is developed by an Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/16/21	$250,000,000	Series A	Boxer Capital BVF Partners Cormorant Asset Management EcoR1 Capital Franklin Templeton Janus Henderson Investors Logos Capital T. Rowe Price Associates Venrock Healthcare Partners Vida Ventures Wellington Management Company	undisclosed